If you enjoy this content, please share it with a colleague
Bracco Diagnostics
RELATED CONTENT
December 16, 2010 – Bracco Imaging demonstrated how its customized evidence-based diagnostic imaging solutions are meeting the demands of an evolving radiology market at the Radiological Society of North America (RSNA) meeting.
Bracco offers contrast imaging agents for computed tomography (CT), magnetic resonance imaging (MRI), angiography and ...
October 19, 2010 — CardioGen-82 (Rubidium Rb 82 Generator) when used with positron emission tomography (PET) myocardial perfusion imaging (MPI) has been shown to produce “reasonably low radiation exposure” of 3.7mSv for a complete rest/stress study. 1
June 14, 2010 – A radio tracer is quickly gaining popularity among cardiologists in the United States.
Automated contrast media injectors are used in cardiac imaging to help improve patient safety and enhance image quality. These devices can control contrast dosage, record the amount used, speed injections to keep up with faster computed tomography (CT) scanners, and warn clinicians of potential hazards, such as air embolisms or extravasations.
The biggest challenge in applying best practices in radiology workflow is seeing the big picture. The entire imaging cycle includes identifying the patient data, conducting the imaging exam according to the proper protocols, and then streamlining and processing the data in a timely manner.
Bracco Diagnostics and Acist Medical Systems featured the EmpowerCTA contrast injector, updated with integrated, pre-programmed multislice CT protocols for IsoVue-370 (iopamidol injection)
Robert G. Mitchell, senior manager, contrast imaging solutions, explains how Bracco Diagnostics' acquisition of E-Z-EM further positions the company as a global leader in diagnostic imaging in radiology and cardiology. The merger allows for significant growth opportunities as E-Z-EM complements Bracco's comprehensive repertoire of diagnostic imaging agents.
November 18, 2009 – The Centers for Medicaid and Medicare Services (CMS) recently announced it will increase the reimbursement for positron emission tomography (PET) cardiac procedures in 2010.
December 1, 2008 – At RSNA 2008, Bracco highlighted studies of its products that were the subject of multiple studies this past year, which reportedly demonstrated the company’s dedication to the manufacture of products that provide clinical safety and efficacy, including the following: